EODData

MEMBERSHIP REGISTER LOG IN

FRA, 9LB: LEGEND BIOTECH SP.ADS/2

07 Nov 2025
LAST:

27.20

CHANGE:
 0.80		OPEN:
27.80		HIGH:
27.80		ASK:
0.00		VOLUME:
150
CHG(%):
2.86		PREV:
28.00		LOW:
27.00		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2527.8027.8027.0027.20150
06 Nov 2527.6028.0027.4028.00150
05 Nov 2527.6028.0027.6027.80150
04 Nov 2527.2028.4027.2027.60150
03 Nov 2527.8028.2027.6027.80150
31 Oct 2527.8028.8027.8028.00150
30 Oct 2527.6028.0027.6027.80150
29 Oct 2528.0028.0027.4027.60150
28 Oct 2527.4027.8027.4027.80150
27 Oct 2527.8027.8027.2027.40150

COMPANY PROFILE

Name:LEGEND BIOTECH SP.ADS/2
About:Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. The company was founded in 2014 and is headquartered in Somerset, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:2101 Cottontail Lane, Somerset, NJ, United States, 08873
Website:https://www.legendbiotech.com
ISIN:US52490G1022
LEI:254900EIUFZTW136H859

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-28.75 
Forward P/E:-22.95 
PEG Ratio:-22.95 
Price to Sales:6.49 
Price to Book:4.99 
Profit Margin:-0.41 
Operating Margin:-0.09 
Return on Assets:-0.08 
Return on Equity:-0.30 
Revenue:690.3M 
Shares:184.57M 
Market Cap:5.02B 

TECHNICAL INDICATORS

MA5:27.681.8%
MA10:27.701.8%
MA20:27.792.2%
MA50:28.243.8%
MA100:30.2311.1%
MA200:30.6012.5%
RSI14:36.84 
WPR14:-100.00 
MTM14:-1.00
ROC14:-0.04 
ATR:0.66 
Week High:28.805.9%
Week Low:27.000.7%
Month High:29.608.8%
Month Low:26.6012.5%
Year High:42.2555.3%
Year Low:24.3911.5%
Volatility:18.83